157 related articles for article (PubMed ID: 11597452)
1. Recent insights into poliovirus pathogenesis.
Ohka S; Nomoto A
Trends Microbiol; 2001 Oct; 9(10):501-6. PubMed ID: 11597452
[TBL] [Abstract][Full Text] [Related]
2. Molecular aspects of poliovirus pathogenesis.
Nomoto A
Proc Jpn Acad Ser B Phys Biol Sci; 2007 Dec; 83(8):266-75. PubMed ID: 24367151
[TBL] [Abstract][Full Text] [Related]
3. Poliovirus attenuation and pathogenesis in a transgenic mouse model for poliomyelitis.
Racaniello VR; Ren R; Bouchard M
Dev Biol Stand; 1993; 78():109-16. PubMed ID: 8388820
[TBL] [Abstract][Full Text] [Related]
4. [Analysis of dissemination pathways for poliovirus].
Ohka S
Uirusu; 2009 Jun; 59(1):107-14. PubMed ID: 19927995
[TBL] [Abstract][Full Text] [Related]
5. Transgenic mice and the pathogenesis of poliomyelitis.
Racaniello VR; Ren R
Arch Virol Suppl; 1994; 9():79-86. PubMed ID: 8032284
[TBL] [Abstract][Full Text] [Related]
6. The molecular basis of poliovirus neurovirulence.
Ohka S; Nomoto A
Dev Biol (Basel); 2001; 105():51-8. PubMed ID: 11763337
[TBL] [Abstract][Full Text] [Related]
7. One hundred years of poliovirus pathogenesis.
Racaniello VR
Virology; 2006 Jan; 344(1):9-16. PubMed ID: 16364730
[TBL] [Abstract][Full Text] [Related]
8. Tissue-specific replicating capacity of a chimeric poliovirus that carries the internal ribosome entry site of hepatitis C virus in a new mouse model transgenic for the human poliovirus receptor.
Yanagiya A; Ohka S; Hashida N; Okamura M; Taya C; Kamoshita N; Iwasaki K; Sasaki Y; Yonekawa H; Nomoto A
J Virol; 2003 Oct; 77(19):10479-87. PubMed ID: 12970433
[TBL] [Abstract][Full Text] [Related]
9. Poliovirus-sensitive transgenic mice as a new animal model.
Koike S; Horie H; Sato Y; Ise I; Taya C; Nomura T; Yoshioka I; Yonekawa H; Nomoto A
Dev Biol Stand; 1993; 78():101-7. PubMed ID: 8388819
[TBL] [Abstract][Full Text] [Related]
10. Retrograde transport of intact poliovirus through the axon via the fast transport system.
Ohka S; Yang WX; Terada E; Iwasaki K; Nomoto A
Virology; 1998 Oct; 250(1):67-75. PubMed ID: 9770421
[TBL] [Abstract][Full Text] [Related]
11. Transgenic mice expressing a human poliovirus receptor: a new model for poliomyelitis.
Ren RB; Costantini F; Gorgacz EJ; Lee JJ; Racaniello VR
Cell; 1990 Oct; 63(2):353-62. PubMed ID: 2170026
[TBL] [Abstract][Full Text] [Related]
12. Transgenic mice carrying the human poliovirus receptor: new animal models for study of poliovirus neurovirulence.
Horie H; Koike S; Kurata T; Sato-Yoshida Y; Ise I; Ota Y; Abe S; Hioki K; Kato H; Taya C
J Virol; 1994 Feb; 68(2):681-8. PubMed ID: 8289371
[TBL] [Abstract][Full Text] [Related]
13. Comparison of neuropathogenicity of poliovirus type 3 in transgenic mice bearing the poliovirus receptor gene and cynomolgus monkeys.
Nagata N; Iwasaki T; Ami Y; Harashima A; Hatano I; Suzaki Y; Yoshii K; Yoshii T; Nomoto A; Kurata T
Vaccine; 2001 Apr; 19(23-24):3201-8. PubMed ID: 11312016
[TBL] [Abstract][Full Text] [Related]
14. Neurovirulence test for oral live poliovaccines using poliovirus-sensitive transgenic mice.
Abe S; Ota Y; Koike S; Kurata T; Horie H; Nomura T; Hashizume S; Nomoto A
Virology; 1995 Feb; 206(2):1075-83. PubMed ID: 7856082
[TBL] [Abstract][Full Text] [Related]
15. Poliovirus and its cellular receptor: a molecular genetic dissection of a virus/receptor affinity interaction.
Solecki D; Gromeier M; Harber J; Bernhardt G; Wimmer E
J Mol Recognit; 1998; 11(1-6):2-9. PubMed ID: 10076797
[TBL] [Abstract][Full Text] [Related]
16. Poliomyelitis in intraspinally inoculated poliovirus receptor transgenic mice.
Deatly AM; Coleman JW; McMullen G; McAuliffe JM; Jayarama V; Cupo A; Crowley JC; McWilliams T; Taffs RE
Virology; 1999 Mar; 255(2):221-7. PubMed ID: 10069947
[TBL] [Abstract][Full Text] [Related]
17. Expression of the human poliovirus receptor/CD155 gene during development of the central nervous system: implications for the pathogenesis of poliomyelitis.
Gromeier M; Solecki D; Patel DD; Wimmer E
Virology; 2000 Aug; 273(2):248-57. PubMed ID: 10915595
[TBL] [Abstract][Full Text] [Related]
18. Limited trafficking of a neurotropic virus through inefficient retrograde axonal transport and the type I interferon response.
Lancaster KZ; Pfeiffer JK
PLoS Pathog; 2010 Mar; 6(3):e1000791. PubMed ID: 20221252
[TBL] [Abstract][Full Text] [Related]
19. Poliovirus neurovirulence and attenuation, a conceptual framework.
John TJ
Dev Biol Stand; 1993; 78():117-9. PubMed ID: 8388822
[No Abstract] [Full Text] [Related]
20. Multiple pathways for establishment of poliovirus infection.
Arita M; Ohka S; Sasaki Y; Nomoto A
Virus Res; 1999 Aug; 62(2):97-105. PubMed ID: 10507320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
